# Dermata Therapeutics, Inc.: Form DEF 14A, filed Jun 2, 2025

- Company: [Dermata Therapeutics, Inc.](/companies/drma.md) (CIK 1853816)
- Form: DEF 14A
- Filed: 2025-06-02
- Accepted by EDGAR: Jun 2, 2025, 16:05 ET
- Period: 2025-06-02
- Accession: 0001641172-25-013237
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1853816/000164117225013237/formdef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1853816/000164117225013237/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1853816/000164117225013237/formdef14a.htm

Filed Jun 2, 2025.
Source: SEC EDGAR, the filing index for accession 0001641172-25-013237. Last ingested by Listed: Nov 2, 2026, 18:37 ET. No prices; not investment advice.